Titre :
  • Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
Auteur : Eschenhagen, Thomas ; Force, Thomas ; Ewer, Michael S ; de Keulenaer, Gilles W ; Suter, Thomas ; Anker, Stefan D ; Avkiran, Metin ; Azambuja, Evandro ; Balligand, Jean-Luc ; Brutsaert, Dirk L ; Condorelli, Gianluigi ; Hansen, Arne ; Heymans, Stephane ; Hill, Joseph A ; Hirsch, Emilio ; Hilfiker-Kleiner, Denise ; Janssens, Stef ; de Jong, Steven ; Neubauer, Gitte ; Pieske, Burkert ; Ponikowski, Piotr ; Pirmohamed, Munir ; Rauchhaus, Mathias ; Sawyer, Douglas ; Sugden, Peter H ; Wojta, Johann ; Zannad, Faiez ; Shah, Ajay M
Informations sur la publication : European journal of heart failure, 13, 1, (page 1-10)
Statut de publication : Publié, 2011-01
Sujet CREF : Cancérologie
Mots-clés MeSH : Anthracyclines -- adverse effects -- therapeutic use
Antibodies, Monoclonal -- adverse effects -- therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents -- adverse effects -- therapeutic use
Cardiology -- standards
Cardiotoxins
Cardiovascular System -- drug effects
Education
Europe
Heart Failure -- chemically induced
Humans
Neoplasms -- drug therapy
Practice Guidelines as Topic
Receptor, Epidermal Growth Factor -- drug effects
Risk Factors
Sirolimus -- antagonists & inhibitors
Note : Journal Article
Research Support, Non-U.S. Gov't
Review
FLWIN
Langue :
  • Anglais
Identificateurs : urn:issn:1388-9842 
info:doi/10.1093/eurjhf/hfq213
info:pii/hfq213
info:pmid/21169385